The written description requirement in the chemical and
pharmaceutical industries is based on a unique, everevolving
factual situation necessitating the application of
what would otherwise be a technology-neutral statute. In
light of the range of issues presented, drafting,
prosecution and enforcement strategies have become
more complicated, with the courts providing a rather
ambiguous guide as to what is sufficient.